CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Acamprosate calcium

Last Updated: August 29, 2007
Result type: Reports
Project Number: SR0108-000
Product Line: Reimbursement Review

Generic Name: Acamprosate calcium

Brand Name: Campral

Manufacturer: Prempharm Inc.

Therapeutic Area: Alcohol Abstinence

Indications: Alcohol Abstinence

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 27, 2008

Recommendation Type: List with clinical criteria and/or conditions